Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade

被引：0
|
作者：
Lin, Heng
Wei, Shuang
Vatan, Linda
Kryczek, Ilona
Zou, Weiping
机构：
来源：
JOURNAL OF IMMUNOLOGY | 2017年 / 198卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
56.5
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
    Wu, Bogang
    Sun, Xiujie
    Gupta, Harshita B.
    Yuan, Bin
    Li, Jingwei
    Ge, Fei
    Chiang, Huai-Chin
    Zhang, Xiaowen
    Zhang, Chi
    Zhang, Deyi
    Yang, Jing
    Hu, Yanfen
    Curiel, Tyler J.
    Li, Rong
    [J]. ONCOIMMUNOLOGY, 2018, 7 (11):
  • [32] Cimetidine enhances PD-1 blockade efficacy in melanoma by regulating PD-L1 expression on tumor
    Lee, B.
    Kim, D.
    Lee, B.
    Lee, J.
    Shin, K.
    Kim, H.
    Ko, H.
    Kim, B.
    Kim, M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S217 - S217
  • [33] Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma
    Lee, Lik Hang
    Cavalcanti, Marcela S.
    Sega, Neil H.
    Hechtman, Jaclyn F.
    Weiser, Martin R.
    Smith, J. Joshua
    Garcia-Aguilar, Julio
    Sadot, Eran
    Ntiamoah, Peter
    Markowitz, Arnold J.
    Shike, Moshe
    Stadler, Zsofia K.
    Vakiani, Efsevia
    Klimstra, David S.
    Shia, Jinru
    [J]. MODERN PATHOLOGY, 2016, 29 (11) : 1433 - 1442
  • [34] Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade Therapies
    Tan, Zhaoli
    Yue, Chunyan
    Ji, Shoujian
    Zhao, Chuanhua
    Jia, Ru
    Zhang, Yun
    Liu, Rongrui
    Li, Da
    Yu, Qian
    Li, Ping
    Hu, Zhiyuan
    Yang, Yanlian
    Xu, Jianming
    [J]. ONCOLOGIST, 2021, : e2227 - e2238
  • [35] Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN- production via PD-1/PD-L1 blockade in bovine mycoplasmosis
    Goto, Shinya
    Konnai, Satoru
    Okagawa, Tomohiro
    Nishimori, Asami
    Maekawa, Naoya
    Gondaira, Satoshi
    Higuchi, Hidetoshi
    Koiwa, Masateru
    Tajima, Motoshi
    Kohara, Junko
    Ogasawara, Satoshi
    Kato, Yukinari
    Suzuki, Yasuhiko
    Murata, Shiro
    Ohashi, Kazuhiko
    [J]. IMMUNITY INFLAMMATION AND DISEASE, 2017, 5 (03) : 355 - 363
  • [36] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Dimitrios Mathios
    Jacob Ruzevick
    Christopher M. Jackson
    Haiying Xu
    Sagar Shah
    Janis M. Taube
    Peter C. Burger
    Edward F. McCarthy
    Alfredo Quinones-Hinojosa
    Drew M. Pardoll
    Michael Lim
    [J]. Journal of Neuro-Oncology, 2015, 121 : 251 - 259
  • [37] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Mathios, Dimitrios
    Ruzevick, Jacob
    Jackson, Christopher M.
    Xu, Haiying
    Shah, Sagar
    Taube, Janis M.
    Burger, Peter C.
    McCarthy, Edward F.
    Quinones-Hinojosa, Alfredo
    Pardoll, Drew M.
    Lim, Michael
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 251 - 259
  • [38] Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
    Janning, Melanie
    Kobus, Franca
    Babayan, Anna
    Wikman, Harriet
    Velthaus, Janna-Lisa
    Bergmann, Sonja
    Schatz, Stefanie
    Falk, Markus
    Berger, Lars-Arne
    Boettcher, Lisa-Marie
    Paesler, Sarina
    Gorges, Tobias M.
    O'Flaherty, Linda
    Hille, Claudia
    Joosse, Simon A.
    Simon, Ronald
    Tiemann, Markus
    Bokemeyer, Carsten
    Reck, Martin
    Riethdorf, Sabine
    Pantel, Klaus
    Loges, Sonja
    [J]. CANCERS, 2019, 11 (06):
  • [39] PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
    Liu, Jinhua
    Chen, Zichao
    Li, Yaqun
    Zhao, Wenjie
    Wu, JiBiao
    Zhang, Zhen
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [40] PD-1 and PD-L1 prognostic in UTUC
    Louise Stone
    [J]. Nature Reviews Urology, 2017, 14 : 518 - 518
12345